Key information

‍

Active Ingredient : Ursodeoxycholic acid, UDCA

Formulation Type : Tablet

specifications : UDCA 200mg x 500T

Efficacy : Treatment for indications and Improvement of liver function

Indications : Prevention and treatment of acute hepatitis, chronic hepatitis, liver swelling, fatty liver, and jaundice. Improvement of bile secretion failure, liver poisoning, liver dysfunctions caused by liver parasites, etc.

Dosage : Oral administration of 10-15 mg of ursodeoxycholic acid (UDCA) per kg of body weight once or twice a day

99% High-Purity UDCA
Formulated with 99% high-purity UDCA that produced at Daewoong Bio’s c GMP facility

The First UDCA in Tablet form in Korea
- Chewable Tablets
- Enhanced Palatability and Convenience of Administration

Liver Function Improvement
Promotion of Metabolism, Clearance of Waste and Toxins, and Facilitation of Bile Excretion *

[Ref] 1) Clinical features and outcomes in 38 dogs with cholelithiasis receiving conservative or surgical management. J Vet Intern Med. 2021 Nov-Dec; 35(6): 2730–2742